Prevnar 13 Advisory Committee Review Moved Back To November
This article was originally published in The Pink Sheet Daily
Executive Summary
Revised schedule allows FDA to evaluate additional data on concomitant use of Pfizer's pneumococcal disease vaccine with flu vaccine for older adults, but could cause extra delays at CDC.